mangalore today
name
name
name
Wednesday, November 21
Boscossnamename

 

Gulf Medical University Conducts Seminar on Use of Anti-Diabetic Medicines

Gulf Medical University Conducts Seminar on Use of Anti-Diabetic Medicines


Mangalore Today News Network

Dubai, Dec 16, 2015: The College of Pharmacy of Gulf Medical University (GMU), the leading private medical university in the region owned and operated by Thumbay Group, held a seminar titled “Safe, Effective and Affordable Use of Anti-Diabetic Medicines” at the University campus in Al Jurf, Ajman on Friday, 11th December 2015, organized by the Health Communications Division of Thumbay Group.


Gulf Medical University

 

Gulf Medical University

 

Gulf Medical University 3

 

Gulf Medical University

 

Gulf Medical University


The seminar was attended by a number of healthcare professionals. Topics discussed included scientific efficacy and safety profiles of novel approaches to the management of hyperglycemia in type 2 diabetes, review of current oral anti-diabetic products and their future developments, current trends and future challenges of insulin drug delivery systems, clinical pharmacokinetics and drug-drug interactions of newer anti-diabetics, dose adjustments of anti-diabetic medicines in patients with renal and hepatic impairment, prevention and management of rare but serious adverse events of anti-diabetics, and the implications and guidelines for the safe use of intravenous insulin in emergency.

Speakers at the seminar included Dr. Kiran Kumar (Specialist - Department of Internal Medicine, GMC Hospital and Research Centre – Ajman) and the following Assistant Professors and Lecturer of the College of Pharmacy, GMU: Dr. Ibrahim Elsayed, Dr. Shery Jacob, Dr. SurajRadhamani, Sr. Dixon Thomas, Dr. SubishPalaian and Dr. Mukesh Kumar. Certificates were distributed to the seminar attendees.


Write Comment | E-Mail To a Friend   | Facebook | Twitter | Print
Write your Comments on this Article
Your Name
Native Place / Place of Residence
Your E-mail
Your Comment
You have characters left.
Security Validation
Enter the characters in the image above